Medtronic’s PulseSelect Pulsed Field Ablation System for the treatment of both paroxysmal and persistent atrial fibrillation has become the first PFA device to earn FDA approval.
Medtronic 1st to win FDA approval for irregular heartbeat device
Medtronic’s PulseSelect Pulsed Field Ablation System for the treatment of both paroxysmal and persistent atrial fibrillation has become the first PFA device to earn FDA approval.